****Registration for this event is now closed, for registration enquires please email [email protected]**** 

Belgium is a vibrant Life Science ecosystem, gathering excellence on the whole value chain that led to a continuous pipeline of successful biotech companies including the likes of Galapagos, Ablynx, ArgenX, Mithra, Iteos or Univercells.

The scientific excellence and infrastructure support including investment, facility and networks is making it a partner of choice for those involved in the sector.

On 10 May, you’ll have the chance to meet with their key representatives, hear from some of the most exciting Belgian companies and join a discussion on collaboration and investment opportunities between the UK and Belgium in a post Brexit context.

See the list of companies attending from Belgium

The event is free to attend

There will be opportunity for some UK companies to pitch in front of the Belgium delegation which should be relevant to those interested in developing closer connection with Belgium. Please contact [email protected] if interested.

Programme:

10:00  Registration and Coffee

10:30 Welcome remarks and introduction of the Belgian ecosystem

11:00 Companies pitches x 6

CPI - fertiga - Leaf Expression Systems - MultiplAIHealth - Olys Pharma - Radiomics

11:30  Coffee break

12:00 Companies pitches x 12

Auxin Surgery - neobe Therapeutics - Charles River - Drishti Discoveries N-Side - Secoya Technologies - Boostcode - Xpress Biologics - Biostrand - Icometrix - 2 Bridge - Anabiotec 

13:00  Lunch and networking

14:00  Panel discussion: “Issues, challenges, opportunities and solutions post-TCA” (The EU–UK Trade and Cooperation Agreement)

Chair: Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership, Clarivate

Panelists:
Viola Hay, KTN
Laurent Pacheco, Oyster Venture Partners
Fiona du Monceau, ExeVir
Jan Wauters, Flanders Invest and Trade

15:30  Closing remarks by Belgian Minister

15:35  Networking

16:30 End